BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 14687988)

  • 21. Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.
    Wolach O; Fraser A; Luchiansky M; Shapiro C; Radnay J; Shpilberg O; Lishner M; Lahav M
    Hematol Oncol; 2015 Mar; 33(1):42-7. PubMed ID: 24470400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of lymphoid neoplasms in bone marrow by flow cytometric analysis and comparison to bone marrow aspiration and biopsy.
    Promsuwicha O; Songmuang W; Auewarakul CU
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S210-5. PubMed ID: 23590044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of low-grade NHL patients with bone marrow involvement.
    Gronich N; Radnay J; Shapiro H; Manor Y; Lahav M; Lishner M
    Eur J Clin Invest; 2007 Apr; 37(4):305-9. PubMed ID: 17373966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
    Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
    Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified.
    Quereux G; Frot AS; Brocard A; Leux C; Renaut JJ; Dreno B
    Eur J Dermatol; 2009; 19(3):216-20. PubMed ID: 19251565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
    Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens.
    Almasri NM; Zaer FS; Iturraspe JA; Braylan RC
    Mod Pathol; 1997 Jul; 10(7):650-6. PubMed ID: 9237173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients.
    Morice WG; Kurtin PJ; Hodnefield JM; Shanafelt TD; Hoyer JD; Remstein ED; Hanson CA
    Mayo Clin Proc; 2008 Jul; 83(7):776-85. PubMed ID: 18613994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
    Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
    Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates.
    Engels K; Oeschger S; Hansmann ML; Hillebrand M; Kriener S
    Hum Pathol; 2007 Sep; 38(9):1402-11. PubMed ID: 17560629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
    Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
    Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biclonal low grade B-cell lymphoma confirmed by both flow cytometry and karyotypic analysis, in spite of a normal kappa/lambda Ig light chain ratio.
    Delville JP; Heimann P; El Housni H; Boutriaux M; Jeronnez A; Remmelink M; Lasudry J; Pradier O; Kentos A
    Am J Hematol; 2007 Jun; 82(6):473-80. PubMed ID: 17211842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells.
    Babusíková O; Zelezníková T
    Neoplasma; 2004; 51(5):345-51. PubMed ID: 15640938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow biopsy in non-Hodgkin lymphoma: a morphological study.
    Kumar S; Rau AR; Naik R; Kini H; Mathai AM; Pai MR; Khadilkar UN
    Indian J Pathol Microbiol; 2009; 52(3):332-8. PubMed ID: 19679954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of morphology, flow cytometry and PCR assay to detect bone marrow infiltration in B-cell non-Hodgkin's lymphomas.
    Carulli G; Orciuolo E; Cannizzo E; Bianchi G; Giuntini S; Ottaviano V; Galimberti S; Marini A; Buda G; Ghimenti M; Petrini M
    Clin Ter; 2010; 161(3):253-8. PubMed ID: 20589357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.
    Kim S; Kim H; Kang H; Kim J; Eom H; Kim T; Yoon SS; Suh C; Lee D;
    J Hematol Oncol; 2013 Oct; 6():76. PubMed ID: 24220305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.